Sex differences in type 2 diabetes: focus on disease course and outcomes
Lisa Arnetz,1,2 Neda Rajamand Ekberg,1,2 Michael Alvarsson1,2 1Department of Molecular Medicine and Surgery, Karolinska Institutet, 2Department of Endocrinology, Metabolism and Diabetes, Stockholm, Sweden Background: Women with type 2 diabetes (T2D) are less likely to reach the goals for hemoglobi...
Guardado en:
Autores principales: | Arnetz L, Ekberg NR, Alvarsson M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fdd2dd7c0ce64d25b5d0457bd398e3f8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes
por: Gallwitz B
Publicado: (2013) -
Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin
por: Bo Ahrén
Publicado: (2010) -
Management of diabetes across the course of disease: minimizing obesity-associated complications
por: Apovian CM
Publicado: (2011) -
Sexual dysfunction in diabetic women: prevalence and differences in type 1 and type 2 diabetes mellitus
por: Mazzilli R, et al.
Publicado: (2015) -
SGLT2 inhibitors – an insulin-independent therapeutic approach for treatment of type 2 diabetes: focus on canagliflozin
por: Seufert J
Publicado: (2015)